Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Application of Molecular Methods for Carbapenemase Detection.

Bilozor A, Balode A, Chakhunashvili G, Chumachenko T, Egorova S, Ivanova M, Kaftyreva L, Kõljalg S, Kõressaar T, Lysenko O, Miciuleviciene J, Mändar R, Lis DO, Wesolowska MP, Ratnik K, Remm M, Rudzko J, Rööp T, Saule M, Sepp E, Shyshporonok J, Titov L, Tsereteli D, Naaber P.

Front Microbiol. 2019 Aug 2;10:1755. doi: 10.3389/fmicb.2019.01755. eCollection 2019.

2.

First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1.

Tratulyte S, Miciuleviciene J, Kuisiene N.

Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1953-1959. doi: 10.1007/s10096-019-03633-9. Epub 2019 Jul 20.

PMID:
31327067
3.

Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey.

Idelevich EA, Seifert H, Sundqvist M, Scudeller L, Amit S, Balode A, Bilozor A, Drevinek P, Kocak Tufan Z, Koraqi A, Lamy B, Mareković I, Miciuleviciene J, Müller Premru M, Pascual A, Pournaras S, Saegeman V, Schønheyder HC, Schrenzel J, Strateva T, Tilley R, Wiersinga WJ, Zabicka D, Carmeli Y, Becker K; ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES).

Clin Microbiol Infect. 2019 Apr 10. pii: S1198-743X(19)30143-0. doi: 10.1016/j.cmi.2019.03.024. [Epub ahead of print]

PMID:
30980927
4.

Differences in extended-spectrum beta-lactamase producing Escherichia coli virulence factor genes in the Baltic Sea region.

Lillo J, Pai K, Balode A, Makarova M, Huik K, Kõljalg S, Ivanova M, Kaftyreva L, Miciuleviciene J, Naaber P, Parv K, Pavelkovich A, Rööp T, Toompere K, Suzhaeva L, Sepp E.

Biomed Res Int. 2014;2014:427254. doi: 10.1155/2014/427254. Epub 2014 Aug 28.

5.

Detection of carbapenemase-producing enterobacteriaceae in the baltic countries and st. Petersburg area.

Pavelkovich A, Balode A, Edquist P, Egorova S, Ivanova M, Kaftyreva L, Konovalenko I, Kõljalg S, Lillo J, Lipskaya L, Miciuleviciene J, Pai K, Parv K, Pärna K, Rööp T, Sepp E, Stšepetova J, Naaber P.

Biomed Res Int. 2014;2014:548960. doi: 10.1155/2014/548960. Epub 2014 Mar 4.

6.

Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.

Kupcinskas L, Rasmussen L, Jonaitis L, Kiudelis G, Jørgensen M, Urbonaviciene N, Tamosiunas V, Kupcinskas J, Miciuleviciene J, Kadusevicius E, Berg D, Andersen LP.

APMIS. 2013 May;121(5):431-6. doi: 10.1111/apm.12012. Epub 2012 Oct 19.

PMID:
23078193
7.

Bacteremic urinary tract infection in hospitalized older patients-are any currently available diagnostic criteria sensitive enough?

Woodford HJ, Graham C, Meda M, Miciuleviciene J.

J Am Geriatr Soc. 2011 Mar;59(3):567-8. doi: 10.1111/j.1532-5415.2010.03284.x. No abstract available.

PMID:
21391956
8.

[Economic evaluation of nosocomial infections in pediatric intensive care units in Lithuania].

Gurskis V, Kėvalas R, Kerienė V, Vaitkaitienė E, Miciulevičienė J, Dagys A, Ašembergienė J, Grinkevičiūtė D.

Medicina (Kaunas). 2010;46(11):781-9. Lithuanian.

9.

Reduction of nosocomial infections and mortality attributable to nosocomial infections in pediatric intensive care units in Lithuania.

Gurskis V, Asembergiene J, Kevalas R, Miciuleviciene J, Pavilonis A, Valinteliene R, Dagys A.

Medicina (Kaunas). 2009;45(3):203-13.

10.

Helicobacter pylori genotypes in Lithuanian patients with chronic gastritis and duodenal ulcer.

Miciuleviciene J, Calkauskas H, Jonaitis L, Kiudelis G, Tamosiūnas V, Praskevicius A, Kupcinskas L, Berg D.

Medicina (Kaunas). 2008;44(6):449-54.

11.

Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe.

Bozdogan B, Appelbaum PC, Kelly LM, Hoellman DB, Tambic-Andrasevic A, Drukalska L, Hryniewicz W, Hupkova H, Jacobs MR, Kolman J, Konkoly-Thege M, Miciuleviciene J, Pana M, Setchanova L, Trupl J, Urbaskova P.

Clin Microbiol Infect. 2003 Jul;9(7):741-5.

12.

Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers.

Bozdogan B, Appelbaum PC, Kelly LM, Hoellman DB, Tambic-Andrasevic A, Drukalska L, Hryniewicz W, Hupkova H, Jacobs MR, Kolman J, Konkoly-Thege M, Miciuleviciene J, Pana M, Setchanova L, Trupl J, Urbaskova P.

Clin Microbiol Infect. 2003 Jul;9(7):653-61.

13.

Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci.

Dailidiene D, Bertoli MT, Miciuleviciene J, Mukhopadhyay AK, Dailide G, Pascasio MA, Kupcinskas L, Berg DE.

Antimicrob Agents Chemother. 2002 Dec;46(12):3940-6.

14.

Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.

Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Andrasevic AT, Drukalska L, Hryniewicz W, Jacobs MR, Kolman J, Miciuleviciene J, Pana M, Setchanova L, Thege MK, Hupkova H, Trupl J, Urbaskova P.

Antimicrob Agents Chemother. 2002 Feb;46(2):546-9.

15.

Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.

Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Andrasevic AT, Drukalska L, Hryniewicz W, Jacobs MR, Kolman J, Miciuleviciene J, Pana M, Setchanova L, Thege MK, Hupkova H, Trupl J, Urbaskova P.

Antimicrob Agents Chemother. 2002 Feb;46(2):371-7.

Supplemental Content

Loading ...
Support Center